Click here for full text access to Diabetes Care. You will need an NHS Athens password to login.
Perspectives on the News American College of Endocrinology Pre - Diabetes Consensus Conference : Part One
Bloomgarden , Z . T .
Page: 2062-2069 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Editorial No need for the needle ( at first )
Davidson , M . B .
Page: 2070-2071 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
Editorial Glycemic control and hypoglycemia : is the loser the winner ?
Perlmuter , L . C . ; Flanagan , B P . ; Shah , P . H . ; Singh , S . P .
Page: 2072-2076 Vol/Issue: 2008 ; VOL 31 ; PART 10 Date: 2008-October
This week's Diabetes Bulletin...
...
Showing posts with label treatment. Show all posts
Showing posts with label treatment. Show all posts
Friday, 7 November 2008
Friday, 10 October 2008
Recent Diabetes related articles in the Big 4
Access
BMJ - current paper copy in library, electronic access 3 months delay - NHS Athens
Lancet - electronic access 2 months delay - NHS Athens
JAMA - current electronic access - NHS Athens
NEJM - current paper copy in library, partial electronic access to recent articles - no password, full text electronic access - 3 months delay - NHS Athens
CME: Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
EDITORIAL: UKPDS and the Legacy Effect
...Kingdom Prospective Diabetes Study (UKPDS) continues to produce important evidence concerning the evolution of type 2 diabetes and its management. Two studies published in this issue of the ...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
EARLY RELEASE: Immunotherapy on Trial for New-Onset Type 1 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
ORIGINAL ARTICLE: Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
...type 2 diabetes who had been assigned to tight or less-tight blood-pressure control revealed that benefits of previously improved control were not sustained when between-group blood-pressure differences equalized. Early improved blood-pressure control in patients with type 2 diabetes and hypertension was associated with a reduced risk of complic...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
EARLY RELEASE: GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
...type 1 diabetes mellitus. This trial assessed the ability of alum-formulated GAD (GAD-alum) to ...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
ORIGINAL ARTICLE: 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
...type 2 diabetes was sustained during 10 years of follow-up. Despite an early loss of glycemic differences, continued microvascular risk reduction and emergent risk reductions for myocardial infarction and death from any cause were observed.
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
CME: 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
[Articles] Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
...type 2 diabetes. We compared the efficacy of a once-weekly formulation of exenatide to that of a twice daily dose.
The Lancet - Oct 3, 2008 10:48 AM
[Comment] Exenatide once weekly in type 2 diabetes
...type 2 diabetes have led to the need for additional treatments that can replace or be safely combined with existing agents. Patients with type 2 diabetes who have not achieved adequate glucose control at the maximum tolerated doses of their oral therapies have had no alternative other than insulin. However, the best insulin regimen is a matter o...
The Lancet - Oct 3, 2008 10:48 AM
CORRESPONDENCE: Intensive Glucose Control in Type 2 Diabetes
...Risk in Diabetes (ACCORD) study (June 12 issue),1 the intensive-therapy group ...
New England Journal of Medicine - Oct 1, 2008 10:54 PM
CME: Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 1, 2008 10:54 PM
ORIGINAL ARTICLE: Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
...type 1 diabetes mellitus who had glycated hemoglobin levels of 7.0 to 10.0% were stratified into three prespecified age groups and were assigned to receive continuous glucose monitoring or usual monitoring. The primary outcome was the change in glycated hemoglobin levels after 26 weeks. Continuous glucose monitoring was associated with improved ...
New England Journal of Medicine - Oct 1, 2008 10:54 PM
[PRACTICE] Early identification and management of chronic kidney disease: summary of NICE guidance
BMJ current issue - Sep 29, 2008 12:40 PM
[NEWS] Aboriginal children are still twice as likely to die as other young Australians
BMJ current issue - Sep 26, 2008 5:54 PM
[Articles] Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
...disease or diabetes with end-organ damage.
The Lancet - Sep 26, 2008 9:50 AM
[PRACTICE] Raised blood glucose concentration
BMJ current issue - Sep 25, 2008 12:46 PM
[NEWS] New reported risks add to concern about bisphenol A in plastics
BMJ current issue - Sep 24, 2008 10:44 AM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM
HEALTH AGENCIES UPDATE: Exenatide Risk
JAMA current issue - Sep 23, 2008 9:30 PM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women--Reply
JAMA current issue - Sep 23, 2008 9:30 PM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM
[RESEARCH] Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification
...diagnosis of diabetes; the WHO-ISH methods additionally included measurement of fasting blood glucose, total cholesterol, and creatinine, urinalysis, and electrocardiography. Main outcome measures Cardiovascular events and total deaths. Results With both methods there was a highly significant association between the level of predicted risk and ...
BMJ current issue - Sep 19, 2008 10:56 AM
[Case Report] No fire without smoke
...type 2 diabetes, and was taking isosorbide mononitrate, dipyridamole, aspirin, allopurinol, simvastatin, ferrous gluconate, furosemide, and gliclazide. She had never smoked.
The Lancet - Sep 19, 2008 10:32 AM
[Correspondence] Hyperglycaemia as a cardiovascular risk factor in diabetes
In their Seminar (May 24, p 1790), Ravi Retnakaran and Bernard Zinman argue, on the basis of the DCCT/EDIC Study, that hyperglycaemia is an important cardiovascular risk factor, and that hyperglycaemia early in the disease course might exert particular harm through “metabolic imprinting/memory”. Another study of intensive versus conventional treatm...
The Lancet - Sep 19, 2008 10:32 AM
ORIGINAL CONTRIBUTION: Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults
...associated with diabetes (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.21-1.60; P < .001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes -glutamyltransferase (OR per 1-SD increase in BPA concentr...
JAMA current issue - Sep 16, 2008 10:08 PM
[Series] Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care
...diabetes, and mental disorders is high in low-income and middle-income countries and is predicted to increase with the ageing of populations, urbanisation, and globalisation of risk factors. Furthermore, HIV/AIDS is increasingly becoming a chronic disorder. An integrated approach to the management of chronic diseases, irrespective of cause, is n...
The Lancet - Sep 12, 2008 10:26 AM
BMJ - current paper copy in library, electronic access 3 months delay - NHS Athens
Lancet - electronic access 2 months delay - NHS Athens
JAMA - current electronic access - NHS Athens
NEJM - current paper copy in library, partial electronic access to recent articles - no password, full text electronic access - 3 months delay - NHS Athens
CME: Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
EDITORIAL: UKPDS and the Legacy Effect
...Kingdom Prospective Diabetes Study (UKPDS) continues to produce important evidence concerning the evolution of type 2 diabetes and its management. Two studies published in this issue of the ...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
EARLY RELEASE: Immunotherapy on Trial for New-Onset Type 1 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
ORIGINAL ARTICLE: Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes
...type 2 diabetes who had been assigned to tight or less-tight blood-pressure control revealed that benefits of previously improved control were not sustained when between-group blood-pressure differences equalized. Early improved blood-pressure control in patients with type 2 diabetes and hypertension was associated with a reduced risk of complic...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
EARLY RELEASE: GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
...type 1 diabetes mellitus. This trial assessed the ability of alum-formulated GAD (GAD-alum) to ...
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
ORIGINAL ARTICLE: 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
...type 2 diabetes was sustained during 10 years of follow-up. Despite an early loss of glycemic differences, continued microvascular risk reduction and emergent risk reductions for myocardial infarction and death from any cause were observed.
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
CME: 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 8, 2008 (2 days ago)
[Articles] Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
...type 2 diabetes. We compared the efficacy of a once-weekly formulation of exenatide to that of a twice daily dose.
The Lancet - Oct 3, 2008 10:48 AM
[Comment] Exenatide once weekly in type 2 diabetes
...type 2 diabetes have led to the need for additional treatments that can replace or be safely combined with existing agents. Patients with type 2 diabetes who have not achieved adequate glucose control at the maximum tolerated doses of their oral therapies have had no alternative other than insulin. However, the best insulin regimen is a matter o...
The Lancet - Oct 3, 2008 10:48 AM
CORRESPONDENCE: Intensive Glucose Control in Type 2 Diabetes
...Risk in Diabetes (ACCORD) study (June 12 issue),1 the intensive-therapy group ...
New England Journal of Medicine - Oct 1, 2008 10:54 PM
CME: Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
(No abstract is available for this citation)
New England Journal of Medicine - Oct 1, 2008 10:54 PM
ORIGINAL ARTICLE: Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes
...type 1 diabetes mellitus who had glycated hemoglobin levels of 7.0 to 10.0% were stratified into three prespecified age groups and were assigned to receive continuous glucose monitoring or usual monitoring. The primary outcome was the change in glycated hemoglobin levels after 26 weeks. Continuous glucose monitoring was associated with improved ...
New England Journal of Medicine - Oct 1, 2008 10:54 PM
[PRACTICE] Early identification and management of chronic kidney disease: summary of NICE guidance
BMJ current issue - Sep 29, 2008 12:40 PM
[NEWS] Aboriginal children are still twice as likely to die as other young Australians
BMJ current issue - Sep 26, 2008 5:54 PM
[Articles] Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
...disease or diabetes with end-organ damage.
The Lancet - Sep 26, 2008 9:50 AM
[PRACTICE] Raised blood glucose concentration
BMJ current issue - Sep 25, 2008 12:46 PM
[NEWS] New reported risks add to concern about bisphenol A in plastics
BMJ current issue - Sep 24, 2008 10:44 AM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM
HEALTH AGENCIES UPDATE: Exenatide Risk
JAMA current issue - Sep 23, 2008 9:30 PM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women--Reply
JAMA current issue - Sep 23, 2008 9:30 PM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM
LETTERS: Effect of Folic Acid and B Vitamins on Cardiovascular Disease in Women
JAMA current issue - Sep 23, 2008 9:30 PM
[RESEARCH] Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification
...diagnosis of diabetes; the WHO-ISH methods additionally included measurement of fasting blood glucose, total cholesterol, and creatinine, urinalysis, and electrocardiography. Main outcome measures Cardiovascular events and total deaths. Results With both methods there was a highly significant association between the level of predicted risk and ...
BMJ current issue - Sep 19, 2008 10:56 AM
[Case Report] No fire without smoke
...type 2 diabetes, and was taking isosorbide mononitrate, dipyridamole, aspirin, allopurinol, simvastatin, ferrous gluconate, furosemide, and gliclazide. She had never smoked.
The Lancet - Sep 19, 2008 10:32 AM
[Correspondence] Hyperglycaemia as a cardiovascular risk factor in diabetes
In their Seminar (May 24, p 1790), Ravi Retnakaran and Bernard Zinman argue, on the basis of the DCCT/EDIC Study, that hyperglycaemia is an important cardiovascular risk factor, and that hyperglycaemia early in the disease course might exert particular harm through “metabolic imprinting/memory”. Another study of intensive versus conventional treatm...
The Lancet - Sep 19, 2008 10:32 AM
ORIGINAL CONTRIBUTION: Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults
...associated with diabetes (OR per 1-SD increase in BPA concentration, 1.39; 95% confidence interval [CI], 1.21-1.60; P < .001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes -glutamyltransferase (OR per 1-SD increase in BPA concentr...
JAMA current issue - Sep 16, 2008 10:08 PM
[Series] Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care
...diabetes, and mental disorders is high in low-income and middle-income countries and is predicted to increase with the ageing of populations, urbanisation, and globalisation of risk factors. Furthermore, HIV/AIDS is increasingly becoming a chronic disorder. An integrated approach to the management of chronic diseases, irrespective of cause, is n...
The Lancet - Sep 12, 2008 10:26 AM
Pediatric Diabetes Volume 9, Issue 5, 2008
Pages: 431-433
Mucosal immunity and type 1 diabetes: looking at the horizon beyond cow's milk
Melissa D Simpson, Jill M Norris
http://www3.interscience.wiley.com/cgi-bin/abstract/121411257/ABSTRACT
Pages: 434-441
Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood
Kristiina LuopajΣrvi, Erkki Savilahti, Suvi M Virtanen, Jorma Ilonen, Mikael Knip, Hans K ┼kerblom, Outi Vaarala
http://www3.interscience.wiley.com/cgi-bin/abstract/120125409/ABSTRACT
Pages: 442-449
Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry
J°rn V Sagen, Lise Bj°rkhaug, Janne Molnes, Helge Rμder, Louise Grevle, Oddmund S°vik, Anders Molven, Pσl R Nj°lstad
http://www3.interscience.wiley.com/cgi-bin/abstract/120125401/ABSTRACT
Pages: 450-459
Diagnosis and treatment of neonatal diabetes: an United States experience†
Julie St°y, Siri Atma W Greeley, Veronica P Paz, Honggang Ye, Ashley N Pastore, Kinga B Skowron, Rebecca B Lipton, Fran R Cogen, Graeme I Bell, Louis H Philipson
http://www3.interscience.wiley.com/cgi-bin/abstract/120848796/ABSTRACT
Pages: 460-463
Cardiorespiratory fitness and physical activity in youth with type 2 diabetes
Gabriel Q Shaibi, Melissa S Faulkner, Marc J Weigensberg, Cynthia Fritschi, Michael I Goran
http://www3.interscience.wiley.com/cgi-bin/abstract/120125407/ABSTRACT
Pages: 464-471
The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors
Zaira Quijada, Mariela Paoli, Yajaira Zerpa, Nolis Camacho, Rosanna Cichetti, Vanessa Villarroel, Gabriela Arata-Bellabarba, Roberto Lanes
http://www3.interscience.wiley.com/cgi-bin/abstract/120125406/ABSTRACT
Pages: 472-479
Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus
Lars Skogsberg, Hans Fors, Ragnar Hanas, JE Chaplin, Elisabeth Lindman, Josefin Skogsberg
http://www3.interscience.wiley.com/cgi-bin/abstract/121382788/ABSTRACT
Pages: 480-487
Assessment of risk factors of poor metabolic control in type 1 diabetic children assisted in a public hospital in Argentina
Marφa B Araujo, Carmen S Mazza
http://www3.interscience.wiley.com/cgi-bin/abstract/121388548/ABSTRACT
Pages: 488-495
Associations of overweight with insulin resistance, β-cell function and inflammatory markers in Chinese adolescents
Alice PS Kong, Kai-Chow Choi, Gary TC Ko, Gary WK Wong, Risa Ozaki, Wing-Yee So, Peter CY Tong, Juliana CN Chan
http://www3.interscience.wiley.com/cgi-bin/abstract/120125408/ABSTRACT
Pages: 496-503
Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnaires
Laura Nardi, Stefano Zucchini, Franco D'Alberton, Silvana Salardi, Giulio Maltoni, Nicoletta Bisacchi, Daniela Elleri, Alessandro Cicognani
http://www3.interscience.wiley.com/cgi-bin/abstract/120125410/ABSTRACT
Pages: 504-507
'Dead-in-bed' syndrome – a diabetes nightmare
Dror Koltin, Denis Daneman
http://www3.interscience.wiley.com/cgi-bin/abstract/120125405/ABSTRACT
Pages: 508-511
Type 1 diabetes, autoimmune thyroid disease, and chronic urticaria
Sharon J Hyman, Wayne G Shreffler, Robert Rapaport
http://www3.interscience.wiley.com/cgi-bin/abstract/120125404/ABSTRACT
Pages: 512-526
Type 2 diabetes mellitus in the child and adolescent
Arlan L Rosenbloom, Janet H Silverstein, Shin Amemiya, Phil Zeitler, Georgeanna J Klingensmith
http://www3.interscience.wiley.com/cgi-bin/abstract/121372844/ABSTRACT
Mucosal immunity and type 1 diabetes: looking at the horizon beyond cow's milk
Melissa D Simpson, Jill M Norris
http://www3.interscience.wiley.com/cgi-bin/abstract/121411257/ABSTRACT
Pages: 434-441
Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood
Kristiina LuopajΣrvi, Erkki Savilahti, Suvi M Virtanen, Jorma Ilonen, Mikael Knip, Hans K ┼kerblom, Outi Vaarala
http://www3.interscience.wiley.com/cgi-bin/abstract/120125409/ABSTRACT
Pages: 442-449
Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry
J°rn V Sagen, Lise Bj°rkhaug, Janne Molnes, Helge Rμder, Louise Grevle, Oddmund S°vik, Anders Molven, Pσl R Nj°lstad
http://www3.interscience.wiley.com/cgi-bin/abstract/120125401/ABSTRACT
Pages: 450-459
Diagnosis and treatment of neonatal diabetes: an United States experience†
Julie St°y, Siri Atma W Greeley, Veronica P Paz, Honggang Ye, Ashley N Pastore, Kinga B Skowron, Rebecca B Lipton, Fran R Cogen, Graeme I Bell, Louis H Philipson
http://www3.interscience.wiley.com/cgi-bin/abstract/120848796/ABSTRACT
Pages: 460-463
Cardiorespiratory fitness and physical activity in youth with type 2 diabetes
Gabriel Q Shaibi, Melissa S Faulkner, Marc J Weigensberg, Cynthia Fritschi, Michael I Goran
http://www3.interscience.wiley.com/cgi-bin/abstract/120125407/ABSTRACT
Pages: 464-471
The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors
Zaira Quijada, Mariela Paoli, Yajaira Zerpa, Nolis Camacho, Rosanna Cichetti, Vanessa Villarroel, Gabriela Arata-Bellabarba, Roberto Lanes
http://www3.interscience.wiley.com/cgi-bin/abstract/120125406/ABSTRACT
Pages: 472-479
Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus
Lars Skogsberg, Hans Fors, Ragnar Hanas, JE Chaplin, Elisabeth Lindman, Josefin Skogsberg
http://www3.interscience.wiley.com/cgi-bin/abstract/121382788/ABSTRACT
Pages: 480-487
Assessment of risk factors of poor metabolic control in type 1 diabetic children assisted in a public hospital in Argentina
Marφa B Araujo, Carmen S Mazza
http://www3.interscience.wiley.com/cgi-bin/abstract/121388548/ABSTRACT
Pages: 488-495
Associations of overweight with insulin resistance, β-cell function and inflammatory markers in Chinese adolescents
Alice PS Kong, Kai-Chow Choi, Gary TC Ko, Gary WK Wong, Risa Ozaki, Wing-Yee So, Peter CY Tong, Juliana CN Chan
http://www3.interscience.wiley.com/cgi-bin/abstract/120125408/ABSTRACT
Pages: 496-503
Quality of life, psychological adjustment and metabolic control in youths with type 1 diabetes: a study with self- and parent-report questionnaires
Laura Nardi, Stefano Zucchini, Franco D'Alberton, Silvana Salardi, Giulio Maltoni, Nicoletta Bisacchi, Daniela Elleri, Alessandro Cicognani
http://www3.interscience.wiley.com/cgi-bin/abstract/120125410/ABSTRACT
Pages: 504-507
'Dead-in-bed' syndrome – a diabetes nightmare
Dror Koltin, Denis Daneman
http://www3.interscience.wiley.com/cgi-bin/abstract/120125405/ABSTRACT
Pages: 508-511
Type 1 diabetes, autoimmune thyroid disease, and chronic urticaria
Sharon J Hyman, Wayne G Shreffler, Robert Rapaport
http://www3.interscience.wiley.com/cgi-bin/abstract/120125404/ABSTRACT
Pages: 512-526
Type 2 diabetes mellitus in the child and adolescent
Arlan L Rosenbloom, Janet H Silverstein, Shin Amemiya, Phil Zeitler, Georgeanna J Klingensmith
http://www3.interscience.wiley.com/cgi-bin/abstract/121372844/ABSTRACT
Friday, 1 August 2008
Big 4 Diabetes articles
Access
BMJ - current paper copy in library, electronic access 3 months delay - NHS Athens
Lancet - electronic access 2 months delay - NHS Athens
JAMA - current electronic access - NHS Athens
NEJM - current paper copy in library, partial electronic access to recent articles - no password
full text electronic access - 3 months delay - NHS Athens
HEALTH AGENCIES UPDATE: Pesticides-Diabetes Link
JAMA current issue - 22 Jul 2008 21:34
EDITORIAL: Diabetes Mellitus--A Call for Papers
JAMA current issue - 22 Jul 2008 21:34
LETTERS: Oral Hypoglycemic Use and the SANDS Trial
JAMA current issue - 22 Jul 2008 21:34
COMMENTARY: Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities
JAMA current issue - 22 Jul 2008 21:34
LETTERS: Oral Hypoglycemic Use and the SANDS Trial--Reply
JAMA current issue - 22 Jul 2008 21:34
HEALTH AGENCIES UPDATE: Drugs and Cancer Risk
JAMA current issue - 22 Jul 2008 21:34
Statins for children?
...hypertension or diabetes, and those whose family history is unknown should also be screened.
The Lancet - 18 Jul 2008 10:44
BOOK REVIEW: Controversies in Treating Diabetes: Clinical and Research Aspects
Shortly before his election as president, John F. Kennedy wrote, "Let us welcome controversial books and controversial authors." To this statement we might add "and books on controversial medical topics," ...
New England Journal of Medicine - 16 Jul 2008 22:27
ORIGINAL CONTRIBUTION: Fetuin-A and Incident Diabetes Mellitus in Older Persons
...type 2 diabetes mellitus is unknown. Objective To determine whether fetuin-A levels are associated with incident diabetes in older persons. Design, Setting, and Participants Observational study among 3075 well-functioning persons aged 70 to 79 years. In this case-cohort study, we retrospectively measured fetuin-A levels in baseline serum among...
JAMA current issue - 8 Jul 2008 21:39
β-cell transplantation for diabetes therapy
In their Comment, Piero Ruggenenti and colleagues outline why they have decided not to continue islet-cell transplantation. We wish to clarify several points for readers.
The Lancet - 4 Jul 2008 10:48
β-cell transplantation for diabetes therapy – Authors' reply
In the largest series of islet transplant recipients treated with a common protocol of islet preparation and post-transplantation care (the Edmonton protocol), only 16 of 36 patients were still insulin-independent at 1 year; 10 had complete graft loss. Consistently, comparative studies have found that only 31% of islet recipients versus 96% of whol...
The Lancet - 4 Jul 2008 10:
β-cell transplantation for diabetes therapy
...treatment of diabetes.
The Lancet - 4 Jul 2008 10:48
β-cell transplantation for diabetes therapy
Piero Ruggenenti and colleagues (March 15, p 883) highlight their failure to establish a clinical islet transplantation programme. Results of islet transplantation are similar to those of the early days of organ transplantation, where initial success rarely met with long-term function. The Edmonton protocol achieved reproducible insulin independenc...
The Lancet - 4 Jul 2008 10:48
CORRECTIONS: Metformin versus Insulin for the Treatment of Gestational Diabetes
...of Gestational Diabetes . In the abstract (page 2003), under Results, the parenthetical information should read "(relative risk, 0.99; 95% confidence interval, 0.80 to ...
New England Journal of Medicine - 2 Jul 2008 22:20
BMJ - current paper copy in library, electronic access 3 months delay - NHS Athens
Lancet - electronic access 2 months delay - NHS Athens
JAMA - current electronic access - NHS Athens
NEJM - current paper copy in library, partial electronic access to recent articles - no password
full text electronic access - 3 months delay - NHS Athens
HEALTH AGENCIES UPDATE: Pesticides-Diabetes Link
JAMA current issue - 22 Jul 2008 21:34
EDITORIAL: Diabetes Mellitus--A Call for Papers
JAMA current issue - 22 Jul 2008 21:34
LETTERS: Oral Hypoglycemic Use and the SANDS Trial
JAMA current issue - 22 Jul 2008 21:34
COMMENTARY: Heart Failure With Preserved Ejection Fraction: Treat Now by Treating Comorbidities
JAMA current issue - 22 Jul 2008 21:34
LETTERS: Oral Hypoglycemic Use and the SANDS Trial--Reply
JAMA current issue - 22 Jul 2008 21:34
HEALTH AGENCIES UPDATE: Drugs and Cancer Risk
JAMA current issue - 22 Jul 2008 21:34
Statins for children?
...hypertension or diabetes, and those whose family history is unknown should also be screened.
The Lancet - 18 Jul 2008 10:44
BOOK REVIEW: Controversies in Treating Diabetes: Clinical and Research Aspects
Shortly before his election as president, John F. Kennedy wrote, "Let us welcome controversial books and controversial authors." To this statement we might add "and books on controversial medical topics," ...
New England Journal of Medicine - 16 Jul 2008 22:27
ORIGINAL CONTRIBUTION: Fetuin-A and Incident Diabetes Mellitus in Older Persons
...type 2 diabetes mellitus is unknown. Objective To determine whether fetuin-A levels are associated with incident diabetes in older persons. Design, Setting, and Participants Observational study among 3075 well-functioning persons aged 70 to 79 years. In this case-cohort study, we retrospectively measured fetuin-A levels in baseline serum among...
JAMA current issue - 8 Jul 2008 21:39
β-cell transplantation for diabetes therapy
In their Comment, Piero Ruggenenti and colleagues outline why they have decided not to continue islet-cell transplantation. We wish to clarify several points for readers.
The Lancet - 4 Jul 2008 10:48
β-cell transplantation for diabetes therapy – Authors' reply
In the largest series of islet transplant recipients treated with a common protocol of islet preparation and post-transplantation care (the Edmonton protocol), only 16 of 36 patients were still insulin-independent at 1 year; 10 had complete graft loss. Consistently, comparative studies have found that only 31% of islet recipients versus 96% of whol...
The Lancet - 4 Jul 2008 10:
β-cell transplantation for diabetes therapy
...treatment of diabetes.
The Lancet - 4 Jul 2008 10:48
β-cell transplantation for diabetes therapy
Piero Ruggenenti and colleagues (March 15, p 883) highlight their failure to establish a clinical islet transplantation programme. Results of islet transplantation are similar to those of the early days of organ transplantation, where initial success rarely met with long-term function. The Edmonton protocol achieved reproducible insulin independenc...
The Lancet - 4 Jul 2008 10:48
CORRECTIONS: Metformin versus Insulin for the Treatment of Gestational Diabetes
...of Gestational Diabetes . In the abstract (page 2003), under Results, the parenthetical information should read "(relative risk, 0.99; 95% confidence interval, 0.80 to ...
New England Journal of Medicine - 2 Jul 2008 22:20
Labels:
B-cell,
Big4,
cancer,
cardiovascular,
oral therapy,
paediatric,
pregnancy,
treatment,
trials
Diabetes Care Vol 31, Part 7, 2008
We have full text access to this journal using NHS Athens. Click here to access.
Tumor necrosis factor - alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome
Author(s):Tesauro , M . ; Schinzari , F . ; Rovella , V . ; Melina , D . ; Mores , N . ; Barini , A . ; Mettimano , M . ; Lauro , D . ; Iantorno , M . ; Quon , M . J
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1439-1441
Meta - Analysis Rosiglitazone and risk of cancer : a meta - analysis of randomized clinical trials
Author(s):Monami , M . ; Lamanna , C . ; Marchionni , N . ; Mannucci , E .
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1455-1460
Perspectives on the News Approaches to treatment of pre - diabetes and obesity and promising new approaches to type 2 diabetes
Author(s):Bloomgarden , Z . T
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1461-1466
Editorial Death to carbohydrate counting ?
Author(s):Davis , N . J . ; Wylie - Rosett , J .
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1467-1468
Tumor necrosis factor - alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome
Author(s):Tesauro , M . ; Schinzari , F . ; Rovella , V . ; Melina , D . ; Mores , N . ; Barini , A . ; Mettimano , M . ; Lauro , D . ; Iantorno , M . ; Quon , M . J
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1439-1441
Meta - Analysis Rosiglitazone and risk of cancer : a meta - analysis of randomized clinical trials
Author(s):Monami , M . ; Lamanna , C . ; Marchionni , N . ; Mannucci , E .
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1455-1460
Perspectives on the News Approaches to treatment of pre - diabetes and obesity and promising new approaches to type 2 diabetes
Author(s):Bloomgarden , Z . T
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1461-1466
Editorial Death to carbohydrate counting ?
Author(s):Davis , N . J . ; Wylie - Rosett , J .
ISSUE:2008 ; VOL 31 ; PART 7 (2008-July)
Page:1467-1468
Labels:
cancer,
Diabetes Care (journal),
diet,
Metabolism.,
obesity.,
treatment,
trials
Friday, 18 July 2008
Latest Diabetes articles in the Big 4
BOOK REVIEW: Controversies in Treating Diabetes: Clinical and Research Aspects
Shortly before his election as president, John F. Kennedy wrote, "Let us welcome controversial books and controversial authors." To this statement we might add "and books on controversial medical topics," ...
New England Journal of Medicine - Jul 16, 2008 (2 days ago)
ORIGINAL CONTRIBUTION: Fetuin-A and Incident Diabetes Mellitus in Older Persons
...type 2 diabetes mellitus is unknown. Objective To determine whether fetuin-A levels are associated with incident diabetes in older persons. Design, Setting, and Participants Observational study among 3075 well-functioning persons aged 70 to 79 years. In this case-cohort study, we retrospectively measured fetuin-A levels in baseline serum among...
JAMA current issue - Jul 8, 2008 9:39 PM
β-cell transplantation for diabetes therapy
In their Comment, Piero Ruggenenti and colleagues outline why they have decided not to continue islet-cell transplantation. We wish to clarify several points for readers.
The Lancet - Jul 4, 2008 10:48 AM
β-cell transplantation for diabetes therapy – Authors' reply
In the largest series of islet transplant recipients treated with a common protocol of islet preparation and post-transplantation care (the Edmonton protocol), only 16 of 36 patients were still insulin-independent at 1 year; 10 had complete graft loss. Consistently, comparative studies have found that only 31% of islet recipients versus 96% of whol...
The Lancet - Jul 4, 2008 10:48 AM
β-cell transplantation for diabetes therapy
...treatment of diabetes.
The Lancet - Jul 4, 2008 10:48 AM
β-cell transplantation for diabetes therapy
Piero Ruggenenti and colleagues (March 15, p 883) highlight their failure to establish a clinical islet transplantation programme. Results of islet transplantation are similar to those of the early days of organ transplantation, where initial success rarely met with long-term function. The Edmonton protocol achieved reproducible insulin independenc...
The Lancet - Jul 4, 2008 10:48 AM
CORRECTIONS: Metformin versus Insulin for the Treatment of Gestational Diabetes
...of Gestational Diabetes . In the abstract (page 2003), under Results, the parenthetical information should read "(relative risk, 0.99; 95% confidence interval, 0.80 to ...
New England Journal of Medicine - Jul 2, 2008 10:20 PM
Book: Handle with care
...Primary Care Diabetes Society conference. I wanted to know more about the disease that, according to the 2002 report by Sir Derek Wanless, threatens to bankrupt the UK's National Health Service (NHS) over the next decade. It already costs the NHS more than £1 billion a year, most of which can be put down to failures in prevention and management ...
The Lancet - Jun 27, 2008 10:17 AM
Chronic kidney disease in Asia
...such as diabetes, hypertension, and metabolic syndrome, have become common and, as a result, chronic kidney disease has become a prevalent comorbidity in the past 10 years.
The Lancet - Jun 27, 2008 10:17 AM
Type 2 diabetes: pathogenesis and treatment
...type 2 diabetes mellitus, several important developments have taken place. Further evidence that the disease has a strong hereditary component led to a vigorous search to identify candidate genes (). This approach uncovered two prevalent polymorphisms (in addition to PPARy and KCNJ11). HNF1B (MODY5) bears a polymorphism associated with type 2 di...
The Lancet - Jun 27, 2008 10:17 AM
[RESEARCH] Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
...type 2 diabetes, renal disease, atrial fibrillation, and rheumatoid arthritis. Results The validation statistics indicated that QRISK2 had improved discrimination and calibration compared with the modified Framingham score. The QRISK2 algorithm explained 43% of the variation in women and 38% in men compared with 39% and 35%, respectively, by the...
BMJ current issue - Jun 27, 2008 12:09 AM
Labels:
B-cell,
cardiovascular,
pregnancy,
renal,
treatment
Friday, 6 June 2008
Recent Diabetes articles in the Big 4
We have full text access to BMJ, NEJM and JAMA
Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
Metabolic syndrome—what is the clinical usefulness?
...events or diabetes in elderly patients, shows that a fasting plasma glucose test is as good as or potentially better than a diagnosis of the metabolic syndrome for predicting diabetes. They also show that a diagnosis of the metabolic syndrome has negligible association with risk of cardiovascular disease; and that the whole is not greater than t...
The Lancet - 10:54 AM (4 hours ago)
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
...disease and diabetes remains uncertain. We investigated to what extent metabolic syndrome and its individual components were related to risk for these two diseases in elderly populations.
The Lancet - 10:54 AM (4 hours ago)
[PRACTICE] Management of type 2 diabetes: summary of updated NICE guidance
BMJ current issue - 12:06 AM (14 hours ago)
[LETTERS] Screen women with gestational diabetes for type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
[PRACTICE] Commentary: controversies in NICE guidance on management of type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
CME: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
(No abstract is available for this citation)
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
ORIGINAL ARTICLE: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
...type 2 diabetes and nephropathy received either aliskiren, an oral direct renin inhibitor, or placebo, in addition to the maximal recommended dose of losartan and optimal antihypertensive therapy. Aliskiren was associated with a reduction in the mean urinary albumin-to-creatinine ratio. This direct renin inhibitor may be renoprotective independe...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
EDITORIAL: Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
The discovery 110 years ago that crude kidney extract elicited a pressor reaction provided the first evidence of the existence of the renin-angiotensin-aldosterone system, a major vasoactive system,1 and the ...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
CLINICAL CROSSROADS: A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
...type 2 diabetes and chronic hypertension who has had a gastric bypass procedure and is planning to conceive. She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery. This article discusses the management of diabetes prior to and during pregnancy, in...
JAMA current issue - Jun 3, 2008 (3 days ago)
JAMA PATIENT PAGE: Pregnancy and Diabetes
JAMA current issue - Jun 3, 2008 (3 days ago)
ORIGINAL CONTRIBUTION: Patient-Important Outcomes in Registered Diabetes Trials
...efficacy of diabetes interventions persist, in part because randomized clinical trials (RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life (morbidity, pain, function). Objective To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient-important outc...
JAMA current issue - Jun 3, 2008 (3 days ago)
Department of Error
...diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736–43—In this Article (March 1), data in the sensitivity and specificity columns of were incorrect, as was the total number of participants above the cutoff of 5·6 mmol/L in the Australian Diabetes, Obesity and Lifestyle Study. The corrected version of the...
The Lancet - May 30, 2008 10:43 AM
CORRECTIONS: Gestational Diabetes -- Setting Limits, Exploring Treatments
...Gestational Diabetes -- Setting Limits, Exploring Treatments . In the paragraph that begins "Also in this issue of the Journal..." (page 2062), the final sentence should have read, "Rates of ...
New England Journal of Medicine - May 28, 2008 10:20 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI--Reply
JAMA current issue - May 27, 2008 9:27 PM
BOOK AND MEDIA REVIEWS: Levin and O'Neal's The Diabetic Foot
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
Metabolic syndrome—what is the clinical usefulness?
...events or diabetes in elderly patients, shows that a fasting plasma glucose test is as good as or potentially better than a diagnosis of the metabolic syndrome for predicting diabetes. They also show that a diagnosis of the metabolic syndrome has negligible association with risk of cardiovascular disease; and that the whole is not greater than t...
The Lancet - 10:54 AM (4 hours ago)
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies
...disease and diabetes remains uncertain. We investigated to what extent metabolic syndrome and its individual components were related to risk for these two diseases in elderly populations.
The Lancet - 10:54 AM (4 hours ago)
[PRACTICE] Management of type 2 diabetes: summary of updated NICE guidance
BMJ current issue - 12:06 AM (14 hours ago)
[LETTERS] Screen women with gestational diabetes for type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
[PRACTICE] Commentary: controversies in NICE guidance on management of type 2 diabetes
BMJ current issue - 12:06 AM (14 hours ago)
CME: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
(No abstract is available for this citation)
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
ORIGINAL ARTICLE: Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
...type 2 diabetes and nephropathy received either aliskiren, an oral direct renin inhibitor, or placebo, in addition to the maximal recommended dose of losartan and optimal antihypertensive therapy. Aliskiren was associated with a reduction in the mean urinary albumin-to-creatinine ratio. This direct renin inhibitor may be renoprotective independe...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
EDITORIAL: Aliskiren and Dual Therapy in Type 2 Diabetes Mellitus
The discovery 110 years ago that crude kidney extract elicited a pressor reaction provided the first evidence of the existence of the renin-angiotensin-aldosterone system, a major vasoactive system,1 and the ...
New England Journal of Medicine - Jun 4, 2008 (2 days ago)
CLINICAL CROSSROADS: A 40-Year-Old Woman With Diabetes Contemplating Pregnancy After Gastric Bypass Surgery
...type 2 diabetes and chronic hypertension who has had a gastric bypass procedure and is planning to conceive. She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery. This article discusses the management of diabetes prior to and during pregnancy, in...
JAMA current issue - Jun 3, 2008 (3 days ago)
JAMA PATIENT PAGE: Pregnancy and Diabetes
JAMA current issue - Jun 3, 2008 (3 days ago)
ORIGINAL CONTRIBUTION: Patient-Important Outcomes in Registered Diabetes Trials
...efficacy of diabetes interventions persist, in part because randomized clinical trials (RCTs) have not measured their effect on patient-important outcomes, ie, death and quality of life (morbidity, pain, function). Objective To systematically determine the extent to which ongoing and future RCTs in diabetes will ascertain patient-important outc...
JAMA current issue - Jun 3, 2008 (3 days ago)
Department of Error
...diagnosis of diabetes: three population-based cross-sectional studies. Lancet 2008; 371: 736–43—In this Article (March 1), data in the sensitivity and specificity columns of were incorrect, as was the total number of participants above the cutoff of 5·6 mmol/L in the Australian Diabetes, Obesity and Lifestyle Study. The corrected version of the...
The Lancet - May 30, 2008 10:43 AM
CORRECTIONS: Gestational Diabetes -- Setting Limits, Exploring Treatments
...Gestational Diabetes -- Setting Limits, Exploring Treatments . In the paragraph that begins "Also in this issue of the Journal..." (page 2062), the final sentence should have read, "Rates of ...
New England Journal of Medicine - May 28, 2008 10:20 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI--Reply
JAMA current issue - May 27, 2008 9:27 PM
BOOK AND MEDIA REVIEWS: Levin and O'Neal's The Diabetic Foot
JAMA current issue - May 27, 2008 9:27 PM
LETTERS: Glucose-Insulin-Potassium Therapy in Patients With STEMI
JAMA current issue - May 27, 2008 9:27 PM
Labels:
Big4,
cardiovascular,
diabetic foot,
Metabolism.,
NICE,
pregnancy,
treatment,
trials
Diabetic Medicine Volume 25, Issue 6, June 2008
We have electronic and print access to this journal. You cannot use your Athens password, please contact the library for login details.
Review Article
Glycaemic control in Type 2 diabetes not for sidelining
P. Narendran
pages 639–642
Special Article
Association of British Clinical Diabetologists (ABCD) and Diabetes-UK survey of specialist diabetes services in the UK, 2006. 1. The consultant physician perspective
P. H. Winocour, C. Gosden, C. Walton, D. Nagi, B. Turner, R. Williams, J. James and R. I. G. Holt
pages 643–65
Original Articles
Genetics
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation
E. D’Amato, P. Tammaro, T. J. Craig, A. Tosi, R. Giorgetti, R. Lorini and F. M. Ashcroft
pages 651–656
Autosomal dominant transmission of diabetes and congenital hearing impairment secondary to a missense mutation in the WFS1 gene
R. Valéro, S. Bannwarth, S. Roman, V. Paquis-Flucklinger and B. Vialettes
pages 657–661
Original Articles
Treatment
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial
S. Del Prato, L. Blonde, L. Martinez, B. Göke, V. Woo, A. Millward, R. Gomis, B. Canovatchel, T. Strack, D. Lawrence and N. Freemantle on behalf of the EXPERIENCE Trial Team
pages 662–670
Original Articles
Metabolism
Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
A. Mari, A. Tura, G. Pacini, A. Kautzky-Willer and E. Ferrannini
pages 671–677
Maternal vitamin D deficiency, ethnicity and gestational diabetes
R. J. Clifton-Bligh, P. McElduff and A. McElduff
pages 678–684
Obesity and intermediate clinical outcomes in diabetes: evidence of a differential relationship across ethnic groups
C. Millett, K. Khunti, J. Gray, S. Saxena, G. Netuveli and A. Majeed
pages 685–691
Original Articles
Complications
Small-fibre involvement in diabetic patients with neuropathic foot pain
E. Vlckova-Moravcova, J. Bednarik, J. Belobradkova and C. Sommer
pages 692–699
Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study
L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, D. Mauricio, G. R. Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbancic, K. Van Acker, J. Van Baal, F. Van Merode and N. Schaper
pages 700–707
Outcomes of pregnancies in women with pre-gestational diabetes mellitus and gestational diabetes mellitus; a population-based study in New South Wales, Australia, 19982002
A. W. Shand, J. C. Bell, A. McElduff, J. Morris and C. L. Roberts
pages 708–715
Original Articles
Psychological Issues and Education
A psychosocial taxonomy of patients with diabetes: validation in a primary care setting
T. P. Guck, M. A. Banfield, S. M. Tran, J. F. Levy, M. D. Goodman, E. J. Barone and A. L. Goeser
pages 716–721
Effects of the Diabetes Manual 1:1 structured education in primary care
J. A. Sturt, S. Whitlock, C. Fox, H. Hearnshaw, A. J. Farmer, M. Wakelin, S. Eldridge, F. Griffiths and J. Dale
pages 722–731
Original Articles
Health Economics and Care Delivery
Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis
A.-B. Wiréhn, A. Andersson, C. J. Östgren and J. Carstensen
pages 732–737
Expenditure on diabetes treatments and achievement of glycaemic control: retrospective analysis
S. Eaton, S. Brent, N. Shah and G. Masters
pages 738–742
Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 20012006
J. A. McKnight, A. D. Morris, D. Cline, N. Peden, C. Fischbacher, S. Wild on behalf of The Scottish Diabetes Survey Monitoring Group
pages 743–746
Short Reports
Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study
J. Saltevo, M. Vanhala, H. Kautiainen, E. Kumpusalo and M. Laakso
pages 747–750
Notification of random hyperglycaemia to general practitioners by an emergency medicine team: impact of a simple intervention plan
G. M. Nicholls, A. M. Dissanayake and W. Hazell
pages 751–754
Continuous rise in incidence of childhood Type 1 diabetes in Germany
S. Ehehalt, G. Blumenstock, A. M. Willasch, R. Hub, M. B. Ranke and A. Neu, for the DIARY-study Group Baden-Württemberg
pages 755–757
Review Article
Glycaemic control in Type 2 diabetes not for sidelining
P. Narendran
pages 639–642
Special Article
Association of British Clinical Diabetologists (ABCD) and Diabetes-UK survey of specialist diabetes services in the UK, 2006. 1. The consultant physician perspective
P. H. Winocour, C. Gosden, C. Walton, D. Nagi, B. Turner, R. Williams, J. James and R. I. G. Holt
pages 643–65
Original Articles
Genetics
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation
E. D’Amato, P. Tammaro, T. J. Craig, A. Tosi, R. Giorgetti, R. Lorini and F. M. Ashcroft
pages 651–656
Autosomal dominant transmission of diabetes and congenital hearing impairment secondary to a missense mutation in the WFS1 gene
R. Valéro, S. Bannwarth, S. Roman, V. Paquis-Flucklinger and B. Vialettes
pages 657–661
Original Articles
Treatment
The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial
S. Del Prato, L. Blonde, L. Martinez, B. Göke, V. Woo, A. Millward, R. Gomis, B. Canovatchel, T. Strack, D. Lawrence and N. Freemantle on behalf of the EXPERIENCE Trial Team
pages 662–670
Original Articles
Metabolism
Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
A. Mari, A. Tura, G. Pacini, A. Kautzky-Willer and E. Ferrannini
pages 671–677
Maternal vitamin D deficiency, ethnicity and gestational diabetes
R. J. Clifton-Bligh, P. McElduff and A. McElduff
pages 678–684
Obesity and intermediate clinical outcomes in diabetes: evidence of a differential relationship across ethnic groups
C. Millett, K. Khunti, J. Gray, S. Saxena, G. Netuveli and A. Majeed
pages 685–691
Original Articles
Complications
Small-fibre involvement in diabetic patients with neuropathic foot pain
E. Vlckova-Moravcova, J. Bednarik, J. Belobradkova and C. Sommer
pages 692–699
Delivery of care to diabetic patients with foot ulcers in daily practice: results of the Eurodiale Study, a prospective cohort study
L. Prompers, M. Huijberts, J. Apelqvist, E. Jude, A. Piaggesi, K. Bakker, M. Edmonds, P. Holstein, A. Jirkovska, D. Mauricio, G. R. Tennvall, H. Reike, M. Spraul, L. Uccioli, V. Urbancic, K. Van Acker, J. Van Baal, F. Van Merode and N. Schaper
pages 700–707
Outcomes of pregnancies in women with pre-gestational diabetes mellitus and gestational diabetes mellitus; a population-based study in New South Wales, Australia, 19982002
A. W. Shand, J. C. Bell, A. McElduff, J. Morris and C. L. Roberts
pages 708–715
Original Articles
Psychological Issues and Education
A psychosocial taxonomy of patients with diabetes: validation in a primary care setting
T. P. Guck, M. A. Banfield, S. M. Tran, J. F. Levy, M. D. Goodman, E. J. Barone and A. L. Goeser
pages 716–721
Effects of the Diabetes Manual 1:1 structured education in primary care
J. A. Sturt, S. Whitlock, C. Fox, H. Hearnshaw, A. J. Farmer, M. Wakelin, S. Eldridge, F. Griffiths and J. Dale
pages 722–731
Original Articles
Health Economics and Care Delivery
Age-specific direct healthcare costs attributable to diabetes in a Swedish population: a register-based analysis
A.-B. Wiréhn, A. Andersson, C. J. Östgren and J. Carstensen
pages 732–737
Expenditure on diabetes treatments and achievement of glycaemic control: retrospective analysis
S. Eaton, S. Brent, N. Shah and G. Masters
pages 738–742
Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 20012006
J. A. McKnight, A. D. Morris, D. Cline, N. Peden, C. Fischbacher, S. Wild on behalf of The Scottish Diabetes Survey Monitoring Group
pages 743–746
Short Reports
Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study
J. Saltevo, M. Vanhala, H. Kautiainen, E. Kumpusalo and M. Laakso
pages 747–750
Notification of random hyperglycaemia to general practitioners by an emergency medicine team: impact of a simple intervention plan
G. M. Nicholls, A. M. Dissanayake and W. Hazell
pages 751–754
Continuous rise in incidence of childhood Type 1 diabetes in Germany
S. Ehehalt, G. Blumenstock, A. M. Willasch, R. Hub, M. B. Ranke and A. Neu, for the DIARY-study Group Baden-Württemberg
pages 755–757
Diabetic Medicine - Online Early articles
We do not have electronic access to the Online Early articles of this journal. They may be available via interlibrary loan, please contact the library to request.
We do have electronic access to articles that have already been published in Diabetic Medicine. Please contact the library for login details.
Case reports
Spontaneous resolution of Diabetic Macular Edema after discontinuation of thiazolidenediones
E Liazos, D M Broadbent, N Beare and N Kumar
Short report
‘Educator talk’ and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomised controlled trial
T C Skinner, M E Carey, S Cradock, H M Dallosso, H Daly, M J Davies, Y Doherty, S Heller, K Khunti and L Oliver, DESMOND Collaborative
Original articles
Lower levels of circulating IGF-I in type 1 diabetic women with frequent severe hypoglycaemia during pregnancy
L. Ringholm Nielsen, A. Juul, U. Pedersen-Bjergaard, B. Thorsteinsson, P. Damm and E. R. Mathiesen
Stratified Analyses for Selecting Appropriate Target Patients with Diabetic Peripheral Neuropathy for Long-Term Treatment with an Aldose Reductase Inhibitor, Epalrestat
N. HOTTA, MD R. KAWAMORI, MD Y. ATSUMI, MD M. BABA, MD H. KISHIKAWA, MD J. NAKAMURA, MD S. OIKAWA, MD N. YAMADA, MD H. YASUDA, MD Y. SHIGETA, MD THE ADCT STUDY GROUP
Review
Addressing insulin resistance in type 1 diabetes
Pang TTL and Narendran P
Letters
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients
V. S. E. Jeganathan, N. Cheung and T. Y. Wong
Reply
Reply
G. Targher
Original Articles
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
E. Karlsson, N. Shaat and L. Groop
Short Reports
Relationship between autonomic neuropathy and hypertensionare we underestimating the problem?
I. Istenes, K. Keresztes, Z. Hermányi, Z. Putz, P. Vargha, R. Gandhi, S. Tesfaye and P. Kempler
Review Articles
Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesitydiabetes?
P. R. Flatt
Original Articles
Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)
S. Å. Eide, H. Ræder, S. Johansson, K. Midthjell, O. Søvik, P. R. Njølstad and A. Molven
Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study
M. C. Adriaanse, J. M. Dekker, R. J. Heine, F. J. Snoek, A. J. Beekman, C. D. Stehouwer, L. M. Bouter, G. Nijpels and F. Pouwer
Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women
A.-K. Eriksson, A. Ekbom, F. Granath, A. Hilding, S. Efendic and C.-G. Östenson
We do have electronic access to articles that have already been published in Diabetic Medicine. Please contact the library for login details.
Case reports
Spontaneous resolution of Diabetic Macular Edema after discontinuation of thiazolidenediones
E Liazos, D M Broadbent, N Beare and N Kumar
Short report
‘Educator talk’ and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomised controlled trial
T C Skinner, M E Carey, S Cradock, H M Dallosso, H Daly, M J Davies, Y Doherty, S Heller, K Khunti and L Oliver, DESMOND Collaborative
Original articles
Lower levels of circulating IGF-I in type 1 diabetic women with frequent severe hypoglycaemia during pregnancy
L. Ringholm Nielsen, A. Juul, U. Pedersen-Bjergaard, B. Thorsteinsson, P. Damm and E. R. Mathiesen
Stratified Analyses for Selecting Appropriate Target Patients with Diabetic Peripheral Neuropathy for Long-Term Treatment with an Aldose Reductase Inhibitor, Epalrestat
N. HOTTA, MD R. KAWAMORI, MD Y. ATSUMI, MD M. BABA, MD H. KISHIKAWA, MD J. NAKAMURA, MD S. OIKAWA, MD N. YAMADA, MD H. YASUDA, MD Y. SHIGETA, MD THE ADCT STUDY GROUP
Review
Addressing insulin resistance in type 1 diabetes
Pang TTL and Narendran P
Letters
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients
V. S. E. Jeganathan, N. Cheung and T. Y. Wong
Reply
Reply
G. Targher
Original Articles
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
E. Karlsson, N. Shaat and L. Groop
Short Reports
Relationship between autonomic neuropathy and hypertensionare we underestimating the problem?
I. Istenes, K. Keresztes, Z. Hermányi, Z. Putz, P. Vargha, R. Gandhi, S. Tesfaye and P. Kempler
Review Articles
Dorothy Hodgkin Lecture 2008 Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesitydiabetes?
P. R. Flatt
Original Articles
Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)
S. Å. Eide, H. Ræder, S. Johansson, K. Midthjell, O. Søvik, P. R. Njølstad and A. Molven
Symptoms of depression in people with impaired glucose metabolism or Type 2 diabetes mellitus: The Hoorn Study
M. C. Adriaanse, J. M. Dekker, R. J. Heine, F. J. Snoek, A. J. Beekman, C. D. Stehouwer, L. M. Bouter, G. Nijpels and F. Pouwer
Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women
A.-K. Eriksson, A. Ekbom, F. Granath, A. Hilding, S. Efendic and C.-G. Östenson
Diabetes, Obesity and Metabolism (Online Early articles)
We do not have electronic or print access to this journal. Articles may be avaialble via interlibrary loan. Please contact the library to request articles.
Original Articles
Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials
E. Mannucci, M. Monami, C. Lamanna, G. F. Gensini N. Marchionni
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats
A. K. Dhalla, M. Santikul, J. W. Chisholm, L. Belardinelli G. M. Reaven
Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study
Y. Gao, X. H. Guo J. A. Vaz PRESENT Study Group
Short Reports
FTY720, a sphingosine-1-phosphate receptor modulator, reverses high-fat dietinduced weight gain, insulin resistance and adipose tissue inflammation in C57BL/6 mice
M. R. Kendall C. J. Hupfeld
Review Articles
Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
P. Raskin
Original Articles
Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naïve type 2 diabetic patients
H. Masuda, M. Sakamoto, J. Irie, A. Kitaoka, K. Shiono, G. Inoue, K. Atsuda S. Yamada
The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes
Z. Li, Q. Zhang, X. Peng, Y. Wu, Y. Xia X. Liu
Review Articles
Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women
Szalat Auryan Raz Itamar
Original Articles
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified releasebased regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)
A. H. Barnett, A. J. Krentz, K. Strojek, J. Sieradzki, F. Azizi, M. Embong, S. Imamoglu, J. Peruiová, V. Uliiansky G. Winkler
All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study
K. B. Doshi, S. R. Kashyap, D. M. Brennan, B. M. Hoar, L. Cho B. J. Hoogwerf
Review Articles
The role of reninangiotensinaldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection
Hussam Abuissa James O’Keefe, Jr
Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation
Eliot A. Brinton
Original Articles
Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss
P. Linscheid, M. Christ-Crain, R. Stoeckli, C. E. Reusch, T. A. Lutz, B. Müller U. Keller
Original Articles
Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials
E. Mannucci, M. Monami, C. Lamanna, G. F. Gensini N. Marchionni
Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats
A. K. Dhalla, M. Santikul, J. W. Chisholm, L. Belardinelli G. M. Reaven
Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study
Y. Gao, X. H. Guo J. A. Vaz PRESENT Study Group
Short Reports
FTY720, a sphingosine-1-phosphate receptor modulator, reverses high-fat dietinduced weight gain, insulin resistance and adipose tissue inflammation in C57BL/6 mice
M. R. Kendall C. J. Hupfeld
Review Articles
Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes
P. Raskin
Original Articles
Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naïve type 2 diabetic patients
H. Masuda, M. Sakamoto, J. Irie, A. Kitaoka, K. Shiono, G. Inoue, K. Atsuda S. Yamada
The influence of adiponectin gene polymorphism on the pioglitazone response in the Chinese with type 2 diabetes
Z. Li, Q. Zhang, X. Peng, Y. Wu, Y. Xia X. Liu
Review Articles
Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women
Szalat Auryan Raz Itamar
Original Articles
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified releasebased regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)
A. H. Barnett, A. J. Krentz, K. Strojek, J. Sieradzki, F. Azizi, M. Embong, S. Imamoglu, J. Peruiová, V. Uliiansky G. Winkler
All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study
K. B. Doshi, S. R. Kashyap, D. M. Brennan, B. M. Hoar, L. Cho B. J. Hoogwerf
Review Articles
The role of reninangiotensinaldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection
Hussam Abuissa James O’Keefe, Jr
Novel pathways for glycaemic control in type 2 diabetes: focus on bile acid modulation
Eliot A. Brinton
Original Articles
Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss
P. Linscheid, M. Christ-Crain, R. Stoeckli, C. E. Reusch, T. A. Lutz, B. Müller U. Keller
Friday, 23 May 2008
BIG 4 diabetes articles in the last fortnight
-We have full text access to BMJ, NEJM and JAMA
-Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
...type 2 diabetes in people with impaired glucose tolerance, but how long these benefits extend beyond the period of active intervention, and whether such interventions reduce the risk of cardiovascular disease (CVD) and mortality, is unclear. We aimed to assess whether intensive lifestyle interventions have a long-term effect on the risk of diabe...
The Lancet - 10:20 AM (48 minutes ago)
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial
...type 2 diabetes.
The Lancet - 10:20 AM (48 minutes ago)
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
...type 2 diabetes mellitus have increased cardiovascular disease risk compared with those without diabetes. Treatment of the residual risk, other than blood pressure and LDL-cholesterol control, remains important as the rate of diabetes increases worldwide. The accelerated atherosclerosis and cardiovascular disease in diabetes is likely to be mult...
The Lancet - 10:20 AM (48 minutes ago)
Diabetes care for south Asian patients: a special case
...type 2 diabetes is rising rapidly worldwide, particularly for south Asian people living in urban areas. South Asian individuals have a four-fold to six-fold greater risk of developing type 2 diabetes, contract the disease at an earlier age, and have higher rates of renal and cardiovascular complications than do other ethnic groups. Although prev...
The Lancet - 10:20 AM (48 minutes ago)
Lifestyle intervention, diabetes, and cardiovascular disease
...type 2 diabetes was first proposed in 1921 by Elliot Joslin who wrote: “There are entirely too many diabetic patients in the country…Therefore, it is proper at the present time to devote attention not alone to treatment, but still more, as in the campaign against the typhoid fever, to prevention. The results may not be quite so striking or as im...
The Lancet - 10:20 AM (48 minutes ago)
Halting the accelerating epidemic of type 1 diabetes
...type 1 diabetes has been steadily increasing worldwide since the middle of the 20th century. The increase has so far been linear and predictable. However, in today's Lancet Valma Harjutsalo and colleagues show that in Finland, which has the highest incidence of type 1 diabetes in the world, the incidence predicted for 2010 on the basis of data f...
The Lancet - 10:20 AM (48 minutes ago)
Profile: Jean Claude Mbanya: fighting diabetes in Africa
...advocates for diabetes in Africa, almost ended up as a chemical engineer. As he prepared to graduate from high school in Cameroon, Mbanya had a scholarship in hand to study chemical engineering in the USA. But at the urging of his father—a local chief who had diabetes and had long dreamed of becoming a doctor—Mbanya went to the capital city, to ...
The Lancet - 10:20 AM (48 minutes ago)
Book: A meeting point for cardiologists and diabetologists
...years for diabetes. Heart disease accounts for between two-thirds and three-quarters of all deaths in type 2 diabetes, and is the leading cause of death in type 1, not least because it abolishes the premenopausal protection from coronary disease enjoyed by women. 30 years ago, these effects attracted less attention: a coronary epidemic was sweep...
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes – Authors' reply
...people with diabetes whose baseline LDL cholesterol concentration was 2·6 mmol/L or less. As previously reported, reducing LDL cholesterol with statin therapy by a further 1 mmol/L in this group resulted in a significant 32% relative reduction in the incidence of major vascular events (136 [9·8%] vs 170 [12·2%], rate ratio 0·68; p=0·02, webfigur...
The Lancet - 10:20 AM (48 minutes ago)
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
...type 1 diabetes worldwide, reaching 40 per 100 000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future.
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes
...patients with diabetes (Jan 12, p 117) raises the question as to whether all patients with diabetes should be on statins.
The Lancet - 10:20 AM (48 minutes ago)
The global challenge of diabetes
...annual American Diabetes Association Scientific Sessions taking place between June 6–10 in San Francisco, much of the focus in this week's Lancet is on the link between diabetes mellitus and heart disease.
The Lancet - 10:20 AM (48 minutes ago)
Type 1 diabetes, hyperglycaemia, and the heart
...Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease that might not always be appreciated in view of the fairly young age of patients with this condition. In fact, in type 1 diabetes, the heart is subject to a variety of pathological insults, including accelerated atherosclerosis, cardiac autonomic neuropat...
The Lancet - 10:20 AM (48 minutes ago)
Intensive insulin therapy in newly diagnosed type 2 diabetes
...type 2 diabetes is characterised by worsening hyperglycaemia and progressive deterioration in function of the insulin-secreting pancreatic β cells. Despite intense investigative efforts, the pathophysiological basis underlying β-cell dysfunction (and the concomitant loss of β-cell mass) remains unclear. Nevertheless, the central importance of de...
The Lancet - 10:20 AM (48 minutes ago)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
...type 2 diabetes might improve β-cell function and result in extended glycaemic remissions. We did a multicentre, randomised trial to compare the effects of transient intensive insulin therapy (continuous subcutaneous insulin infusion [CSII] or multiple daily insulin injections [MDI]) with oral hypoglycaemic agents on β-cell function and diabetes...
The Lancet - 10:20 AM (48 minutes ago)
[EDITORIALS] Self monitoring of blood glucose in type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis
...type 2 diabetes: (a) screening for type 2 diabetes to enable early detection and treatment, (b) screening for type 2 diabetes and impaired glucose tolerance, intervening with lifestyle interventions in those with a diagnosis of impaired glucose tolerance to delay or prevent diabetes, (c) as for (b) but with pharmacological interventions, and (d)...
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
...type 2 diabetes mellitus. Design Prospective randomised controlled trial of self monitoring versus no monitoring (control). Setting Hospital diabetes clinics. Participants 184 (111 men) people aged <70 class="entry-source-title-link" href="http://www.google.com/reader/view/feed/http://www.bmj.com/rss/current.xml" target="_blank" closure_hashcode_="295">BMJ current issue - 11:56 PM (11 hours ago)
[EDITORIALS] Screening for and prevention of type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
...type 2 diabetes. Design Incremental cost utility analysis from a healthcare perspective. Data on resource use from the randomised controlled diabetes glycaemic education and monitoring (DiGEM) trial covered 12 months before baseline and 12 months of trial follow-up. Quality of life was measured at baseline and 12 months using the EuroQol EQ-5D q...
BMJ current issue - 11:56 PM (11 hours ago)
CORRESPONDENCE: Multifactorial Intervention and Mortality in Type 2 Diabetes
To the Editor: In their article on aggressive multiagent treatment of risk factors for diabetic complications, Gæde et al. (Feb. ...
New England Journal of Medicine - May 21, 2008 (2 days ago)
ORIGINAL CONTRIBUTION: Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome
Context Experimental data support the hypothesis that oxidized low-density lipoprotein (LDL) is associated with the metabolic syndrome. However, this hypothesis has not been tested in humans. Objective To establish the relation of oxidized LDL with metabolic syndrome in the general community. Design, Setting, and Participants The Coronary Artery...
JAMA current issue - May 20, 2008 (3 days ago)
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes
JAMA current issue - May 13, 2008 9:27 PM
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes--Reply
JAMA current issue - May 13, 2008 9:27 PM
[NEWS] Prevalence of pre-existing diabetes in pregnancy doubled in seven years in a Californian population
BMJ current issue - May 8, 2008 11:40 PM
-Full text access to The Lancet is available two months after publication. Articles published within the last two months are available via interlibrary loan
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
...type 2 diabetes in people with impaired glucose tolerance, but how long these benefits extend beyond the period of active intervention, and whether such interventions reduce the risk of cardiovascular disease (CVD) and mortality, is unclear. We aimed to assess whether intensive lifestyle interventions have a long-term effect on the risk of diabe...
The Lancet - 10:20 AM (48 minutes ago)
Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomised controlled trial
...type 2 diabetes.
The Lancet - 10:20 AM (48 minutes ago)
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
...type 2 diabetes mellitus have increased cardiovascular disease risk compared with those without diabetes. Treatment of the residual risk, other than blood pressure and LDL-cholesterol control, remains important as the rate of diabetes increases worldwide. The accelerated atherosclerosis and cardiovascular disease in diabetes is likely to be mult...
The Lancet - 10:20 AM (48 minutes ago)
Diabetes care for south Asian patients: a special case
...type 2 diabetes is rising rapidly worldwide, particularly for south Asian people living in urban areas. South Asian individuals have a four-fold to six-fold greater risk of developing type 2 diabetes, contract the disease at an earlier age, and have higher rates of renal and cardiovascular complications than do other ethnic groups. Although prev...
The Lancet - 10:20 AM (48 minutes ago)
Lifestyle intervention, diabetes, and cardiovascular disease
...type 2 diabetes was first proposed in 1921 by Elliot Joslin who wrote: “There are entirely too many diabetic patients in the country…Therefore, it is proper at the present time to devote attention not alone to treatment, but still more, as in the campaign against the typhoid fever, to prevention. The results may not be quite so striking or as im...
The Lancet - 10:20 AM (48 minutes ago)
Halting the accelerating epidemic of type 1 diabetes
...type 1 diabetes has been steadily increasing worldwide since the middle of the 20th century. The increase has so far been linear and predictable. However, in today's Lancet Valma Harjutsalo and colleagues show that in Finland, which has the highest incidence of type 1 diabetes in the world, the incidence predicted for 2010 on the basis of data f...
The Lancet - 10:20 AM (48 minutes ago)
Profile: Jean Claude Mbanya: fighting diabetes in Africa
...advocates for diabetes in Africa, almost ended up as a chemical engineer. As he prepared to graduate from high school in Cameroon, Mbanya had a scholarship in hand to study chemical engineering in the USA. But at the urging of his father—a local chief who had diabetes and had long dreamed of becoming a doctor—Mbanya went to the capital city, to ...
The Lancet - 10:20 AM (48 minutes ago)
Book: A meeting point for cardiologists and diabetologists
...years for diabetes. Heart disease accounts for between two-thirds and three-quarters of all deaths in type 2 diabetes, and is the leading cause of death in type 1, not least because it abolishes the premenopausal protection from coronary disease enjoyed by women. 30 years ago, these effects attracted less attention: a coronary epidemic was sweep...
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes – Authors' reply
...people with diabetes whose baseline LDL cholesterol concentration was 2·6 mmol/L or less. As previously reported, reducing LDL cholesterol with statin therapy by a further 1 mmol/L in this group resulted in a significant 32% relative reduction in the incidence of major vascular events (136 [9·8%] vs 170 [12·2%], rate ratio 0·68; p=0·02, webfigur...
The Lancet - 10:20 AM (48 minutes ago)
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
...type 1 diabetes worldwide, reaching 40 per 100 000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future.
The Lancet - 10:20 AM (48 minutes ago)
Statins and diabetes
...patients with diabetes (Jan 12, p 117) raises the question as to whether all patients with diabetes should be on statins.
The Lancet - 10:20 AM (48 minutes ago)
The global challenge of diabetes
...annual American Diabetes Association Scientific Sessions taking place between June 6–10 in San Francisco, much of the focus in this week's Lancet is on the link between diabetes mellitus and heart disease.
The Lancet - 10:20 AM (48 minutes ago)
Type 1 diabetes, hyperglycaemia, and the heart
...Type 1 diabetes is associated with a substantially increased risk of cardiovascular disease that might not always be appreciated in view of the fairly young age of patients with this condition. In fact, in type 1 diabetes, the heart is subject to a variety of pathological insults, including accelerated atherosclerosis, cardiac autonomic neuropat...
The Lancet - 10:20 AM (48 minutes ago)
Intensive insulin therapy in newly diagnosed type 2 diabetes
...type 2 diabetes is characterised by worsening hyperglycaemia and progressive deterioration in function of the insulin-secreting pancreatic β cells. Despite intense investigative efforts, the pathophysiological basis underlying β-cell dysfunction (and the concomitant loss of β-cell mass) remains unclear. Nevertheless, the central importance of de...
The Lancet - 10:20 AM (48 minutes ago)
Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
...type 2 diabetes might improve β-cell function and result in extended glycaemic remissions. We did a multicentre, randomised trial to compare the effects of transient intensive insulin therapy (continuous subcutaneous insulin infusion [CSII] or multiple daily insulin injections [MDI]) with oral hypoglycaemic agents on β-cell function and diabetes...
The Lancet - 10:20 AM (48 minutes ago)
[EDITORIALS] Self monitoring of blood glucose in type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis
...type 2 diabetes: (a) screening for type 2 diabetes to enable early detection and treatment, (b) screening for type 2 diabetes and impaired glucose tolerance, intervening with lifestyle interventions in those with a diagnosis of impaired glucose tolerance to delay or prevent diabetes, (c) as for (b) but with pharmacological interventions, and (d)...
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
...type 2 diabetes mellitus. Design Prospective randomised controlled trial of self monitoring versus no monitoring (control). Setting Hospital diabetes clinics. Participants 184 (111 men) people aged <70 class="entry-source-title-link" href="http://www.google.com/reader/view/feed/http://www.bmj.com/rss/current.xml" target="_blank" closure_hashcode_="295">BMJ current issue - 11:56 PM (11 hours ago)
[EDITORIALS] Screening for and prevention of type 2 diabetes
BMJ current issue - 11:56 PM (11 hours ago)
[RESEARCH] Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
...type 2 diabetes. Design Incremental cost utility analysis from a healthcare perspective. Data on resource use from the randomised controlled diabetes glycaemic education and monitoring (DiGEM) trial covered 12 months before baseline and 12 months of trial follow-up. Quality of life was measured at baseline and 12 months using the EuroQol EQ-5D q...
BMJ current issue - 11:56 PM (11 hours ago)
CORRESPONDENCE: Multifactorial Intervention and Mortality in Type 2 Diabetes
To the Editor: In their article on aggressive multiagent treatment of risk factors for diabetic complications, Gæde et al. (Feb. ...
New England Journal of Medicine - May 21, 2008 (2 days ago)
ORIGINAL CONTRIBUTION: Association Between Circulating Oxidized Low-Density Lipoprotein and Incidence of the Metabolic Syndrome
Context Experimental data support the hypothesis that oxidized low-density lipoprotein (LDL) is associated with the metabolic syndrome. However, this hypothesis has not been tested in humans. Objective To establish the relation of oxidized LDL with metabolic syndrome in the general community. Design, Setting, and Participants The Coronary Artery...
JAMA current issue - May 20, 2008 (3 days ago)
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes
JAMA current issue - May 13, 2008 9:27 PM
LETTERS: Surgical vs Behavioral Therapy for Weight Loss in Patients With Type 2 Diabetes--Reply
JAMA current issue - May 13, 2008 9:27 PM
[NEWS] Prevalence of pre-existing diabetes in pregnancy doubled in seven years in a Californian population
BMJ current issue - May 8, 2008 11:40 PM
Subscribe to:
Posts (Atom)
